REAL-WORLD HEALTHCARE COSTS OF LATE-LINE MULTIPLE MYELOMA (MM) PATIENTS ON COMMON MONOTHERAPIES: A GERMAN CLAIMS DATA ANALYSIS

被引:0
|
作者
Kocaata, Z. [1 ]
Wilke, T. [2 ]
Fischer, F. [3 ]
Welte, R. [3 ]
Einsele, H. [4 ]
机构
[1] Ingress Hlth HWM GmbH, Wismar, MV, Germany
[2] Univ Wismar, IPAM, Wismar, Germany
[3] GlaxoSmithKline GmbH & Co KG, Munich, Germany
[4] Univ Cin Wuerzburg, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN114
引用
收藏
页码:S443 / S443
页数:1
相关论文
共 50 条
  • [41] Treatment Rates and Healthcare Costs of Osteoporosis and Fragility Fracture Patients by Physician Specialty: A Real-World Data Analysis
    Singer, Andrea
    McClung, Michael
    Goldstein, Steven
    Kagan, Risa
    Tran, Oth
    Morrow, Cynthia D.
    McDermott, Michele
    Yehoshua, Alon
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1473 - 1473
  • [42] PREVALENCE OF RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA: ANALYSIS OF REAL-WORLD DATABASE
    Bhowmik, D.
    Qian, Y.
    Bond, T. C.
    Wang, X.
    Colman, S.
    Hernandez, R. K.
    Cheng, P. C.
    Intorcia, M.
    VALUE IN HEALTH, 2016, 19 (03) : A141 - A141
  • [43] EARLY DEATH IN MULTIPLE MYELOMA. ANALYSIS OF PATIENTS IN REAL-WORLD PRACTICE
    Lakhwani Lakhwani, S.
    Hernandez Garcia, M. T.
    Lorenzo Barreto, P.
    Cabrera Brito, D.
    Fernandez Gonzalez, M.
    Diaz Gomez, M.
    Raya Sanchez, J. M.
    HAEMATOLOGICA, 2019, 104 : 14 - 15
  • [44] Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis
    Celine Miyazaki
    Takuya Sakashita
    Wonjoo Jung
    Shingo Kato
    Advances in Therapy, 2021, 38 : 2229 - 2247
  • [45] Real-world systemic treatment of patients with psoriasis: A retrospective study based on German claims data
    Heidbrede, Tanja
    Mevius, Antje
    Kessel, Sebastian
    Wilke, Thomas
    Maywald, Ulf
    Thiem, Alexander
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (06): : 621 - 621
  • [46] Survey of the Relevance of Quality of Life (QoL) Questionnaires (QoLQs) Currently Used to Evaluate Multiple Myeloma (MM) Patients' Qol in Real-World MM Patients and Healthcare Professionals (HCPs)
    Bristogiannis, Sotirios
    Lwin, Yadanar
    Lecat, Catherine S. Y.
    Sowter, Joanne
    McCourt, Orla
    Dowling, Emma
    Correia, Nuno
    Rabin, Neil K.
    Xu, Ke
    Sive, Jonathan
    Papanikolaou, Xenofon
    Popat, Rakesh
    Lee, Lydia
    McMillan, Annabel
    Delimpasi, Sosana
    Wechalekar, Ashutosh D.
    Yong, Kwee
    Kyriakou, Charalampia
    BLOOD, 2022, 140 : 12506 - 12507
  • [47] A real-world data analysis of predictors of early mortality after a diagnosis of multiple myeloma
    Grant, Shakira J.
    Wildes, Tanya M.
    Rosko, Ashley E.
    Silberstein, Juliet
    Giri, Smith
    CANCER, 2023, 129 (13) : 2023 - 2034
  • [48] A Real-World Comparison of First-Line Regimens in Transplant Ineligible Patients with Multiple Myeloma
    Abdallah, Nadine
    Chakraborty, Rajshekhar
    Visram, Alissa
    Gayowsky, Anastasia
    Pond, Gregory
    Seow, Hsien
    Kumar, Shaji
    Mian, Hira
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S217 - S218
  • [49] Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
    Kocaata, Zeki
    Wilke, Thomas
    Fischer, Franz
    Welte, Robert
    Einsele, Hermann
    PHARMACOECONOMICS-OPEN, 2022, 6 (04) : 619 - 628
  • [50] Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
    Zeki Kocaata
    Thomas Wilke
    Franz Fischer
    Robert Welte
    Hermann Einsele
    PharmacoEconomics - Open, 2022, 6 : 619 - 628